v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (1,594,508) $ (1,241,262)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of capitalized research and development costs 648,323
Depreciation expense 20,686 1,434
Stock-based compensation 23,888
Changes in operating assets and liabilities:    
Decrease (Increase) in accounts receivable (11,958) 2,386
Decrease in prepaid expenses (20,700) (35,104)
Increase in accounts payable and accrued liabilities 529,568 621,463
Increase in deferred revenues 41,681
Increase in current tax liability 170
Net cash used in operating activities (362,850) (651,083)
CASH FLOWS FROM INVESTING ACTIVITIES    
Capitalization of research and development costs (1,045,572) (1,135,860)
Increase in restrictive deposit (25,208)
Increase in long-term deposit (10,858)
Purchase of property and equipment (38,099) (17,270)
Net cash used in investing activities (1,094,529) (1,178,338)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from sale of common stock 1,100,000
Increase in advance payable - related party 1,420,738 762,924
Net cash provided by financing activities 1,420,738 1,862,924
Net (decrease) increase in cash (36,641) 33,503
Cash, beginning of period 77,200 9,929
Cash, end of period $ 40,559 $ 43,432